Literature DB >> 35432730

Paravalvular Leak.

Fatima Qamar1, Rowa H Attar1, Faisal Nabi1.   

Abstract

Despite improvements and advancements in surgical technique, paravalvular leaks (PVL) continue to present a challenge when caring for patients with prosthetic valve disease.1 Paravalvular leaks result from dehiscence of the surgical ring from the mitral annulus. Some theories suggest that uneven distribution of collagen fibers in the mitral annulus leaves the posterior mitral annulus without a well-formed fibrous structure, which may predispose it to recurrent mechanical injury that leads to PVL. The reported incidence of PVL is 2.2%.2 Risk factors associated with PVL include the presence of mitral annular calcification, infective endocarditis, active steroid use, and continuous surgical suturing, which poses a greater risk than an interrupted surgical approach.3 Risk of PVL varies by prosthesis type, with mechanical prostheses carrying a higher risk of PVL than bioprosthetic valves. Below are images of a 70-year-old male with severe mitral stenosis and pulmonary hypertension who had previously undergone mitral valve commissurotomy and subsequent mitral valve replacement with a bioprosthetic mitral valve. He presented to the hospital with pulmonary edema. Initial transthoracic echocardiogram showed depressed biventricular function with a dehiscence of the bioprosthetic mitral valve and a large eccentric posterior PVL, severe tricuspid regurgitation, and severe pulmonary hypertension. Transesophageal images in Figure 1 illustrate a significant posterior PVL with dehiscence of the prosthetic valve from the mitral annulus. The patient underwent closure of the paravalvular leak with two 18-mm Amplatzer ventricular septal defect occluders (Abbott) with excellent results and trace residual mitral regurgitation post closure ( Figure 2A, 2B ). Copyright:
© 2022 The Author(s).

Entities:  

Keywords:  mitral annulus; paravalvular leak; prosthetic valve disease

Mesh:

Year:  2022        PMID: 35432730      PMCID: PMC8973757          DOI: 10.14797/mdcvj.1096

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


(A) 3-dimensional (3D) enface view of the mitral valve (MV) with the aortic valve (AV) seen in the 12 o’clock position. The mitral bioprosthesis is visualized with a paravalvular defect located posteromedially (red arrow). (B) 3D Trueview image of the mitral valve showing eccentric systolic flow through the paravalvular defect. (A, B) A 3-dimensional enface view of the mitral valve with two Amplatzer ventricular septal defect (Abbott) devices (yellow arrow) well seated within the paravalvular defect. Panel B shows a small amount of residual paravalvular leak. AV: aortic valve; MV: mitral valve
  3 in total

Review 1.  Prosthetic heart valves.

Authors:  W Vongpatanasin; L D Hillis; R A Lange
Journal:  N Engl J Med       Date:  1996-08-08       Impact factor: 91.245

Review 2.  Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement.

Authors:  Carlos E Ruiz; Rebecca T Hahn; Alain Berrebi; Jeffrey S Borer; Donald E Cutlip; Greg Fontana; Gino Gerosa; Reda Ibrahim; Vladimir Jelnin; Hasan Jilaihawi; E Marc Jolicoeur; Chad Kliger; Itzhak Kronzon; Jonathon Leipsic; Francesco Maisano; Xavier Millan; Patrick Nataf; Patrick T O'Gara; Philippe Pibarot; Stephen R Ramee; Charanjit S Rihal; Josep Rodes-Cabau; Paul Sorajja; Rakesh Suri; Julie A Swain; Zoltan G Turi; E Murat Tuzcu; Neil J Weissman; Jose L Zamorano; Patrick W Serruys; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2017-04-25       Impact factor: 24.094

3.  Paravalvular regurgitation after conventional aortic and mitral valve replacement: A benchmark for alternative approaches.

Authors:  Brett F Duncan; Patrick M McCarthy; Jane Kruse; Adin-Cristian Andrei; Zhi Li; Hyde M Russell; Travis O Abicht; Vera H Rigolin; James D Thomas; Charles J Davidson; Robert O Bonow; S Chris Malaisrie
Journal:  J Thorac Cardiovasc Surg       Date:  2015-06-27       Impact factor: 5.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.